CN Patent

CN109305980B — 一种硼酸酯化合物、其合成方法及其用途

Assigned to Chengdu Origin Biotechnology Ltd · Expires 2022-10-11 · 4y expired

What this patent protects

本发明提供了一种适用作蛋白酶体抑制剂的硼酸酯化合物。本发明还提供了所述硼酸酯化合物的制备方法及用途。本发明的硼酸酯化合物与现有的用作蛋白酶体抑制剂的硼酸酯化合物相比，具有稳定性高、活性强、安全性高等优点，更易于合成和纯化，可有效节约生产成本。

USPTO Abstract

本发明提供了一种适用作蛋白酶体抑制剂的硼酸酯化合物。本发明还提供了所述硼酸酯化合物的制备方法及用途。本发明的硼酸酯化合物与现有的用作蛋白酶体抑制剂的硼酸酯化合物相比，具有稳定性高、活性强、安全性高等优点，更易于合成和纯化，可有效节约生产成本。

Drugs covered by this patent

Patent Metadata

Patent number
CN109305980B
Jurisdiction
CN
Classification
—
Expires
2022-10-11
Drug substance claim
No
Drug product claim
No
Assignee
Chengdu Origin Biotechnology Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.